Alliance Pharmaceutical Corp. (NASDAQ:ALLP) of San Diego hasfiled for an offering of 2 million shares of common stock. Ifthe offering is completed, Alliance would have 16.5 millionshares outstanding. Oppenheimer & Co., Lehman Brothers andCowen & Co. are underwriters for the issue. The company plansto use the proceeds to continue development of proprietarypharmaceutical products based on perfluorocarbon andemulsion technologies.

(c) 1997 American Health Consultants. All rights reserved.